CTOs on the Move

XpresSpa Group

www.xpresspagroup.com

 
XpresSpa is the industry-leading luxury travel spa business and wholly owned subsidiary of XpresSpa Group Inc. (Nasdaq: XSPA). Serving almost one million air travelers each year at its 57 locations in the United States, Holland and the United Arab Emirates, including stores in 23 airports and 1 off-airport location at Westfield`s World Trade Center in New York City. XpresSpa offers travelers premium spa services, including massages, reflexology, stress and tension release, manicures, pedicures, facials and waxing. Its Xpres nail, massage and hair blow-out services are designed specifically for the busy traveling customer. In stores and online, XpresSpa also ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
David Kohel
Chief Technology Officer Profile

Similar Companies

Q2 Solutions

Q² Solutions, a Quintiles Quest joint venture Launched in 2015, Q² Solutions (pronounced Q-squared) is a leading global clinical trials laboratory services organization. We help biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. Q² Solutions is a quality driven, responsive partner with strong global experience and deep scientific and medical expertise. The Q² Solutions joint venture was formed by Quintiles and Quest Diagnostics, combining the best of each parent organizations clinical trials laboratory services capabilities.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.

Lantis Laser Inc

Lantis Laser Inc is a Denville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Logistics Health

Logistics Health Incorporated is a La Crosse, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Moore Medical Corp.

Moore Medical Corp. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Farmington, CT. To find more information about Moore Medical Corp., please visit www.mooremedical.com